Treatment Outcome

Effects of alendronate on osteoporosis treatment and levels of related cytokines.

C. T. Liu, Yuan, X. J., and Gao, G. C., “Effects of alendronate on osteoporosis treatment and levels of related cytokines.”, Genet Mol Res, vol. 16, no. 1, 2017.

A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration.

D. Zhang, “A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration.”, Genet Mol Res, vol. 16, no. 1, 2017.

Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.

H. F. Liu, Liu, J. S., Deng, J. H., and Wu, R. R., “Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.”, Genet Mol Res, vol. 15, no. 4, 2016.

Effect of ARMS2 gene polymorphism on intravitreal ranibizumab treatment for neovascular age-related macular degeneration.

H. Bardak, Bardak, Y., Ercalik, Y., E Kumral, T., Imamoglu, S., Gunay, M., Ozbas, H., and Bagci, O., “Effect of ARMS2 gene polymorphism on intravitreal ranibizumab treatment for neovascular age-related macular degeneration.”, Genet Mol Res, vol. 15, no. 4, 2016.

Effect of selective serotonin reuptake inhibitors on expression of 5-HT1AR and neurotransmitters in rats with vascular dementia.

K. Guo, Yin, G., Zi, X. H., Zhu, H. X., and Pan, Q., “Effect of selective serotonin reuptake inhibitors on expression of 5-HT1AR and neurotransmitters in rats with vascular dementia.”, Genet Mol Res, vol. 15, no. 4, 2016.